Bosh sahifaMBIO • NASDAQ
add
Mustang Bio Inc
Yopilish kursi
1,40 $
Kunlik diapazon
1,35 $ - 1,41 $
Yillik diapazon
1,35 $ - 66,50 $
Bozor kapitalizatsiyasi
2,93 mln USD
Oʻrtacha hajm
168,31 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 1,46 mln | -87,50% |
Sof foyda | -1,41 mln | 85,98% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -2,00 | 97,14% |
EBITDA | -1,41 mln | 87,64% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,52 mln | -63,14% |
Jami aktivlari | 7,19 mln | -65,03% |
Jami passivlari | 15,85 mln | -4,28% |
Umumiy kapital | -8,66 mln | — |
Tarqatilgan aksiyalar | 1,78 mln | — |
Narxi/balansdagi bahosi | -0,26 | — |
Aktivlardan daromad | -46,37% | — |
Kapitaldan daromad | 48,83% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,41 mln | 85,98% |
Operatsiyalardan naqd pul | -1,76 mln | 85,39% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 1,01 mln | 305,60% |
Naqd pulning sof oʻzgarishi | -743,00 ming | 87,24% |
Boʻsh pul | -1,20 mln | 51,19% |
Haqida
Mustang Bio is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Tashkil etilgan
2015
Sayt
Xodimlar soni
80
